PROVENTION BIO INC (PRVB)
Institutional ownership reported to the SEC as of Q2 2023, across 19 quarters.
1
Reporting holders
$2.8M
Reported value
0.0%
Held as options
-159
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS ASSET MANAGEMENT AMERICAS INC | $2.8M | 116,324 | 0.00% | 13q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | $2.8M | 116,324 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 160 | $1.5B | 59,129,921 | 67 | 46 | 26 | 4.2% |
| Q4 2022 | 111 | $469.7M | 42,355,293 | 33 | 44 | 15 | 4.7% |
| Q3 2022 | 112 | $196.6M | 42,438,936 | 11 | 50 | 17 | 2.9% |
| Q2 2022 | 115 | $104.0M | 24,990,997 | 27 | 31 | 26 | 3.9% |
| Q1 2022 | 111 | $186.6M | 24,173,988 | 19 | 23 | 34 | 5.2% |
| Q4 2021 | 112 | $146.0M | 24,815,228 | 20 | 32 | 36 | 4.5% |
| Q3 2021 | 114 | $148.6M | 22,301,868 | 15 | 37 | 32 | 3.9% |
| Q2 2021 | 127 | $220.1M | 24,309,041 | 25 | 47 | 32 | 6.9% |
| Q1 2021 | 123 | $260.8M | 23,757,459 | 29 | 50 | 24 | 4.4% |
| Q4 2020 | 106 | $386.1M | 22,521,225 | 16 | 34 | 34 | 1.2% |
| Q3 2020 | 101 | $292.8M | 22,268,852 | 9 | 47 | 28 | 2.4% |
| Q2 2020 | 107 | $307.5M | 20,852,182 | 54 | 31 | 17 | 4.3% |
| Q1 2020 | 64 | $99.4M | 10,458,315 | 20 | 19 | 17 | 3.2% |
| Q4 2019 | 62 | $140.4M | 9,051,292 | 26 | 20 | 11 | 3.9% |
| Q3 2019 | 48 | $42.8M | 6,163,046 | 30 | 13 | 5 | 1.4% |
| Q2 2019 | 28 | $30.9M | 2,554,363 | 24 | 3 | 0 | 0.0% |
| Q1 2019 | 10 | $1.5M | 662,048 | 2 | 0 | 5 | 0.0% |
| Q4 2018 | 10 | $1.1M | 638,696 | 1 | 1 | 0 | 0.0% |